STOCK TITAN
  1. Home
  2. Sec-filings
  3. GILD
  4. [Form 4] GILEAD SCIENCES, INC. Insider Trading Activity

Gilead Sciences (NASDAQ: GILD) exec trades 3,000 shares under 10b5-1 plan

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Johanna Mercier, Chief Comm & Corp Aff Officer of Gilead Sciences, reported an open-market sale of 3,000 shares of common stock on 2026-07-15 at a reported price of $129.9192 per share, with trade prices ranging from $129.45 to $130.23. This sale was made under a Rule 10b5-1 trading plan adopted on February 20, 2025, and she now directly holds 121,234 Gilead shares.

Positive

  • None.

Negative

  • None.
Insider Mercier Johanna
Role Chief Comm & Corp Aff Officer
Sold 3,000 shs ($390K)
Type Security Shares Price Value
Sale Common Stock 3,000 $129.9192 $390K
Holdings After Transaction: Common Stock — 121,234 shares (Direct)
Footnotes (1)
  1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. Sale prices for the transactions reported range from $129.45 to $130.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Shares sold 3,000 shares Open-market sale of Gilead common stock on 2026-07-15
Reported sale price $129.9192 per share Per-share price reported for the 3,000-share sale
Post-transaction holdings 121,234 shares Direct Gilead common stock owned by Johanna Mercier after the sale
Sale price range $129.45–$130.23 per share Range of prices for individual sale transactions, as noted in footnotes
Rule 10b5-1 trading plan regulatory
"The transaction ... is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider trade did Gilead Sciences (GILD) report for Johanna Mercier?
Gilead Sciences reported that Johanna Mercier, its Chief Comm & Corp Aff Officer, executed an open-market sale of 3,000 shares of Gilead common stock on 2026-07-15 and continues to hold a substantial direct position afterward.

How many Gilead (GILD) shares did Johanna Mercier sell and at what price?
Johanna Mercier sold 3,000 Gilead common shares. The Form 4 lists a price of $129.9192 per share, while footnotes state sale prices ranged from $129.45 to $130.23 across the individual trades.

How many Gilead (GILD) shares does Johanna Mercier own after this transaction?
After the reported sale, Johanna Mercier directly owns 121,234 shares of Gilead common stock. This figure reflects her post-transaction holdings as disclosed in the Form 4’s ownership column.

Was Johanna Mercier’s Gilead (GILD) stock sale under a Rule 10b5-1 plan?
Yes. A footnote states the transaction was made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025, indicating the sale was pre-scheduled rather than timed discretionarily.

What type of transaction did Johanna Mercier execute in Gilead (GILD) stock?
The Form 4 describes the transaction as an open-market sale of Gilead common stock, coded “S” for a sale in open market or private transaction, involving 3,000 shares and leaving her with ongoing direct ownership.

What does the price range in Johanna Mercier’s Gilead (GILD) sale represent?
A footnote explains that sale prices for the reported trades ranged from $129.45 to $130.23 per share, with detailed share counts at each price available to the SEC, the issuer, or shareholders upon request.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mercier Johanna
(Last)(First)(Middle)
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
(Street)
FOSTER CITY CALIFORNIA 94404
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Comm & Corp Aff Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/15/2026S(1)3,000D$129.9192(2)121,234D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
2. Sale prices for the transactions reported range from $129.45 to $130.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Remarks:
/s/ Amy Kim by Power of Attorney for Johanna Mercier07/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR